Each week on Saturday morning, the NeurologyLive® team puts together a weekly recap that offers a quick look into some of the top headlines in neurology news that you may have missed.
PHOENIX Study Meets Enrollment, Atogepant and Ubrogepant Safe, ABATE Trial Highlights Targeted Response of Alzheimer Vaccine
Neurology News Network for the week ending February 11, 2023. [WATCH TIME: 3 minutes]
New Diagnostic Criteria Established for MOGAD, FDA Approves Proclaim XR SCS System, Clinical Hold on IKT-148009 Lifted
Neurology News Network for the week ending February 4, 2023. [WATCH TIME: 4 minutes]
Evoke SCS System Shows Positive 36-Month Results, FDA Lifts Hold on FORTIS, Complete Response Letter Issued for Donanemab
Neurology News Network for the week ending January 28, 2023. [WATCH TIME: 4 minutes]
COVID-19 Vaccine and Potential Stroke Concern, Associations Between AEDs and Incident Parkinson, FDA Accepts sBLA for DaxibolinumtoxinA
Neurology News Network for the week ending January 21, 2022. [WATCH TIME: 3 minutes]
24-Hour Levodopa Solution Improves ON Time, Eisai Submits sBLA for Traditional Approval of Lecanemab, Rare Case of Seronegative NMOSD Identified
Neurology News Network for the week ending January 14, 2022. [WATCH TIME: 4 minutes]
FDA Approves Essential Tremor Treatment, Alzheimer's Association Files Request to CMS, Duchenne Therapy ENTR-601-44 Placed on Hold
Neurology News Network for the week ending December 31, 2022. [WATCH TIME: 3 minutes]
WVE-N531's Impact on Exon Skipping, PROs Improved With Early DMT Initiation, Carbon Dioxide Improves Insomnia Sleep
Neurology News Network for the week ending December 24, 2022. [WATCH TIME: 4 minutes]
Genetic Links to PML Identified, MARINA Trial Findings Announced, Educational Videos Improve CPAP Adherence
Neurology News Network for the week ending December 17, 2022. [WATCH TIME: 4 minutes]
Communication Critical for Dravet Syndrome, DNL343 to Enter HEALEY ALS Trial, Combination of Seizures and Dementia Leads to Worse Outcomes
Neurology News Network for the week ending December 10, 2022. [WATCH TIME: 4 minutes]
Donanemab Outperforms Aducanumab in Amyloid Clearance, FDA Grants Priority Review to SRP-9001, Atogepant Improves PROs
Neurology News Network for the week ending December 3, 2022. [WATCH TIME: 3 minutes]
Aquatic Therapy Improves MS Fatigue, MS Disease Pathology Not Defined by Courses, Rituximab Shows Positive Effect in Myasthenia Gravis
Neurology News Network for the week ending November 26, 2022. [WATCH TIME: 4 minutes]
Positive Results of STK-001 in Dravet, Zavegepant Meets Primary End Points, FDA Accepts NDA of Zilucoplan for Myasthenia Gravis
Neurology News Network for the week ending November 19, 2022. [WATCH TIME: 3 minutes]
FDA Rejects BLA for NurOwn, Simvastatin Futile as DMT for Parkinson, Music Potentially Improves Insomnia Symptoms
Neurology News Network for the week ending November 12, 2022. [WATCH TIME: 4 minutes]
Poor Sleep Associated With Cannabis and Alcohol Use, Dietary Approaches in MS, Noninvasive Brain Stimulation Effective in Alzheimer
Neurology News Network for the week ending November 5, 2022. [WATCH TIME: 3 minutes]
Apitegromab Improves Quality of Life in SMA, ARB Therapy Leads to Lowered Epilepsy Risk, Donanemab Reduces Alzheimer-Related Plasma Biomarkers
Neurology News Network for the week ending October 28, 2022. [WATCH TIME: 4 minutes]
Positive Interim Report on Fosgonimeton, Lower ASPECTS Scores Impact Efficacy of EVT, FDA Extends Review of Tofersen
Neurology News Network for the week ending October 22, 2022. [WATCH TIME: 4 minutes]
Phase 3 LIGHTHOUSE Study Initiated, Trend Toward ASMs With Lower Teratogenic Risk, Rituximab Effects on NMOSD, MOGAD
Neurology News Network for the week ending October 15, 2022. [WATCH TIME: 3 minutes]
Ublituximab Outperforms Teriflunomide on ARRs, CNM-Au8 Fails HEALEY ALS Trial, Benefits of Aerobic Exercise in Multiple Sclerosis
Neurology News Network for the week ending October 8, 2022. [WATCH TIME: 3 minutes]
Verdiperstat Fails ALS Study, Lecanemab Shines in Latest Phase 3 Findings, Ofatumumab Continues Superiority Over Teriflunomide
Neurology News Network for the week ending October 1, 2022. [WATCH TIME: 4 minutes]
Rituximab as Initial gMG Treatment, WVE-003 Proves Positive in HD, and Incidence of Guillian-Barré After COVID-19 Vaccination
Neurology News Network for the week ending September 24, 2022. [WATCH TIME: 4 minutes]
Abnormal Vascular Hemodynamics Linked With Tau, Constant Therapy Shows Feasibility in Alzheimer Disease, LIFT-AD Study Amended
Neurology News Network for the week ending September 17, 2022. [WATCH TIME: 4 minutes]
New Study on COVID-19 Vaccinations in MS, FDA Lifts Hold on SRP-5051, Implantable Loop Recorder and Atrial Fibrillation
Neurology News Network for the week ending September 10, 2022. [WATCH TIME: 4 minutes]
FDA Approves Auotinjector for Status Epilepticus, Penumbra System Removes Clots in Ischemic Stroke, Tobacco Use Correlated With Cognitive Decline
Neurology News Network for the week ending September 3, 2022. [WATCH TIME: 4 minutes]
Remote Ischemic Conditioning Improves Post Stroke Outcomes, Opiate Use High in Idiopathic Intracranial Hypertension, Drug Resistant Epilepsy and Increased Mortality
Neurology News Network for the week ending August 27, 2022. [WATCH TIME: 4 minutes]
Results of VISIONARY-MS Study Released, Analysis Complete for Concussion Therapy OXE103, Chronic Kidney Disease Associated With Intracerebral Hemorrhage
Neurology News Network for the week ending August 20, 2022. [WATCH TIME: 4 minutes]
Stigma Adds to Depressive Symptoms in Epilepsy, Parkinson Disease and Diabetes Show Increased Neuroaxonal Damage, ICER Publishes Report on ALS Treatments
Neurology News Network for the week of August 13, 2022. [WATCH TIME: 4 minutes]
Severe Preeclampsia Linked With Neuroinflammation, Neurofilament Light Associated With Memory Function, Discrimination Effects on Cognition
Neurology News Network for the week ending August 6, 2022. [WATCH TIME: 4 minutes]
FDA Accepts NDA for Tofersen, Serious Falls Increased With Hypnotic Medications, Racial Disparities in Sleep of Pregnant Women
Neurology News Network for the week ending July 30, 2022. [WATCH TIME: 4 minutes]
CNM-Au8 Reduces Mortality in ALS, Prenatal Exposure to ASMs Increases Neurodevelopmental Disorders, FDA Grants Tentative Approval to FT218
Neurology News Network for the week ending July 23, 2022. [WATCH TIME: 4 minutes]
Apitegromab Continues Positive Efficacy in SMA, Alzheimer Disease Risk Reduced Through Lifestyle Factors, Depressive Trajectories Predict Stroke Risk
Neurology News Network for the week ending July 16, 2022. [WATCH TIME: 4 minutes]